Gas Kinetics and Metabolism in Anesthesia During Non Steady State

NCT ID: NCT00225381

Last Updated: 2021-03-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2005-08-31

Study Completion Date

2012-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During clinical anesthesia, it is astonishing that CO2 monitoring consists mainly of end-tidal PCO2 to confirm endotracheal intubation and to estimate ventilation, and O2 monitoring consists of a single PO2 measurement to detect a hypoxic gas mixture. Better understanding of how O2 and CO2 kinetics monitoring can define systems pathophysiology will greatly enhance safety in anesthesia by detecting critical events such as abrupt decrease in cardiac output (Q.T) by vena-caval compression during abdominal surgery, occurrence of CO2 pulmonary embolism during laparoscopy, rising tissue O2 consumption (V.O2) during light anesthesia, and onset of anaerobic metabolism (V.CO2 is disproportionately higher than V.O2).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During clinical anesthesia, it is astonishing that CO2 monitoring consists mainly of end-tidal PCO2 to confirm endotracheal intubation and to estimate ventilation, and O2 monitoring consists of a single PO2 measurement to detect a hypoxic gas mixture. Better understanding of how O2 and CO2 kinetics monitoring can define systems pathophysiology will greatly enhance safety in anesthesia by detecting critical events such as abrupt decrease in cardiac output (Q.T) by vena-caval compression during abdominal surgery, occurrence of CO2 pulmonary embolism during laparoscopy, rising tissue O2 consumption (V.O2) during light anesthesia, and onset of anaerobic metabolism (V.CO2 is disproportionately higher than V.O2).

In the previous grant period, discoveries of CO2 kinetics during non-steady state revealed significant gaps in understanding of O2 kinetics. To this end, a 5-compartment lung model of gas kinetics in the body during non-steady state has been developed, that incorporates complex interactions between O2 and CO2 in the lung, blood, and tissues. This computer model was used to formulate the following hypotheses, and will elucidate mechanisms underlying the subsequent measured data in anesthetized patients.

The investigators have already developed two innovative devices that are essential for the V.O2 measurement: A fast response temperature and humidity sensor, and a mixing device (a bymixer) for the measurement of mixed gas fraction, especially designed for anesthesia systems. The investigators have also designed a sophisticated bench system for the validation of both devices, which showed the high accuracy and performance of our measurements.

Hypotheses that will be tested in our overall research theme include:

* That pulmonary O2 uptake (V.O2) in anesthetized patients is much lower than the value quoted in the literature.
* That inhalation anesthesia influences V.O2 differently than total intravenous anesthesia (TIVA).
* That an acute decrease in cardiac output (Q.T) (by patient position change) will transiently decrease V.O2 but the decrease in CO2 elimination (V.CO2) is sustained because tissue CO2 stores are a hundred fold greater than O2 (please see previously approved IRB protocol, HS# 2000-1325).
* That positive end-expiratory pressure (PEEP) decreases V.O2 and V.CO2 due to decreases in Q.T and alveolar ventilation (V.A), and appearance of high ventilation-to-perfusion (V.A/Q.) units (please see previously approved IRB protocol, HS# 2000-1325).
* That Trendelenburg (head down) position increases V.O2 and V.CO2 due to increase in Q.T.
* That V.O2 can help to determine the necessity of blood transfusion.
* That the continuous measurement of the respiratory quotient (RQ=V.CO2/V.O2) can detect transition to anaerobic metabolism.
* That the continuous measurement of the respiratory RQ can be a good alternative to arterial blood gas sampling.
* That the continuous measurement of the respiratory RQ can determine the necessity of nutritional support during long operations.

In this protocol, the investigators will study the clinical implications of these measurements, believing that they are the missing links in anesthesia monitoring. Elucidating the mechanisms underlying this acute pathophysiology will advance the understanding of O2 and CO2 kinetics during non-steady state, and allow the non-invasive diagnosis of critical events during clinical anesthesia conferring increased safety, especially for the majority of healthy patients who receive only non-invasive monitoring.

A separate section of the study, which compliments the metabolic gas exchange study with the bymixer flow system is the examination of respiratory gas with a portable mass-spectrometer to detect volatile organic compounds during anaerobic metabolism. The experimental anaerobic model is adult patients undergoing a surgery that requires tourniquet. Anaerobic metabolism will be detected by acid base balance blood test, the bymixer flow measurement and the mass spectrometer. Anesthesia will be maintained by total intravenous anesthesia (TIVA) and each patient will have an arterial line. No other intervention would be taken. It is an observational type study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthetized Healthy Patients (ASA 1 or 2) in the Supine Position, Excluding Head, Neck and Head Surgeries Anesthetized Patient With Severe Systemic Disease (ASA 3 or 4)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

metabolic gas exchange and cardiac output

connection of measuring device to anesthesia circuit

Intervention Type DEVICE

same as name

placement of esophageal Doppler for cardiac output measurements

Intervention Type PROCEDURE

same

Humidity sensor

Intervention Type DEVICE

Small conventional anesthesia T piece including tiny 2 thermometer inside

A mixing chamber (bymixer)

Intervention Type DEVICE

2 mixing chambers (bymixers) composed of 2 arms where one arm serves as a mixing (passive) arm for the measurement of mixed gas fraction. The bymixer is made of conventional anesthesia supplies and does not influence dead space nor circuit resistance.

Pneumotachometer cuvette

Intervention Type DEVICE

The pneumotachometer cuvette is used by many anesthesia monitors to measure gas flow.

mass spectrometer and anaerobic metabolism

connection of measuring device to anesthesia circuit

Intervention Type DEVICE

same as name

drawing of blood sample through an arterial line, placed according to clinical criteria by primary anesthesia team

Intervention Type PROCEDURE

same

Humidity sensor

Intervention Type DEVICE

Small conventional anesthesia T piece including tiny 2 thermometer inside

A mixing chamber (bymixer)

Intervention Type DEVICE

2 mixing chambers (bymixers) composed of 2 arms where one arm serves as a mixing (passive) arm for the measurement of mixed gas fraction. The bymixer is made of conventional anesthesia supplies and does not influence dead space nor circuit resistance.

Pneumotachometer cuvette

Intervention Type DEVICE

The pneumotachometer cuvette is used by many anesthesia monitors to measure gas flow.

Mass spectrometer sampling port

Intervention Type DEVICE

Designed for the anesthesia tubing and connected at the airway opening. it has small volume (3 mL) and do not influence circuit resistance.

metaboic gas exchange and type of anesthesia induction

connection of measuring device to anesthesia circuit

Intervention Type DEVICE

same as name

Humidity sensor

Intervention Type DEVICE

Small conventional anesthesia T piece including tiny 2 thermometer inside

A mixing chamber (bymixer)

Intervention Type DEVICE

2 mixing chambers (bymixers) composed of 2 arms where one arm serves as a mixing (passive) arm for the measurement of mixed gas fraction. The bymixer is made of conventional anesthesia supplies and does not influence dead space nor circuit resistance.

Pneumotachometer cuvette

Intervention Type DEVICE

The pneumotachometer cuvette is used by many anesthesia monitors to measure gas flow.

metabolic gas exchange and PEEP

connection of measuring device to anesthesia circuit

Intervention Type DEVICE

same as name

adding PEEP during anesthesia

Intervention Type PROCEDURE

same

Humidity sensor

Intervention Type DEVICE

Small conventional anesthesia T piece including tiny 2 thermometer inside

A mixing chamber (bymixer)

Intervention Type DEVICE

2 mixing chambers (bymixers) composed of 2 arms where one arm serves as a mixing (passive) arm for the measurement of mixed gas fraction. The bymixer is made of conventional anesthesia supplies and does not influence dead space nor circuit resistance.

Pneumotachometer cuvette

Intervention Type DEVICE

The pneumotachometer cuvette is used by many anesthesia monitors to measure gas flow.

metabolic gas exchange and trendelenburg position

connection of measuring device to anesthesia circuit

Intervention Type DEVICE

same as name

changing operating room bed position (head down and up position)

Intervention Type PROCEDURE

same

Humidity sensor

Intervention Type DEVICE

Small conventional anesthesia T piece including tiny 2 thermometer inside

A mixing chamber (bymixer)

Intervention Type DEVICE

2 mixing chambers (bymixers) composed of 2 arms where one arm serves as a mixing (passive) arm for the measurement of mixed gas fraction. The bymixer is made of conventional anesthesia supplies and does not influence dead space nor circuit resistance.

Pneumotachometer cuvette

Intervention Type DEVICE

The pneumotachometer cuvette is used by many anesthesia monitors to measure gas flow.

Patients requiring tourniquet during surgery

Patients undergoing orthopaedic surgeries requiring tourniquet intervention. Oxygen consumption and CO2 production were measured before, during and after tourniquet release.

No interventions assigned to this group

Patients prone to metabolic acidosis

Oxygen consumption and CO2 measurements taken during long surgeries prone to metabolic acidosis.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

connection of measuring device to anesthesia circuit

same as name

Intervention Type DEVICE

drawing of blood sample through an arterial line, placed according to clinical criteria by primary anesthesia team

same

Intervention Type PROCEDURE

changing operating room bed position (head down and up position)

same

Intervention Type PROCEDURE

adding PEEP during anesthesia

same

Intervention Type PROCEDURE

placement of esophageal Doppler for cardiac output measurements

same

Intervention Type PROCEDURE

Humidity sensor

Small conventional anesthesia T piece including tiny 2 thermometer inside

Intervention Type DEVICE

A mixing chamber (bymixer)

2 mixing chambers (bymixers) composed of 2 arms where one arm serves as a mixing (passive) arm for the measurement of mixed gas fraction. The bymixer is made of conventional anesthesia supplies and does not influence dead space nor circuit resistance.

Intervention Type DEVICE

Pneumotachometer cuvette

The pneumotachometer cuvette is used by many anesthesia monitors to measure gas flow.

Intervention Type DEVICE

Mass spectrometer sampling port

Designed for the anesthesia tubing and connected at the airway opening. it has small volume (3 mL) and do not influence circuit resistance.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

V&F Instruments, Airsense (www.vandf.com)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult patients at UCIMC who are undergoing anesthesia and surgery are eligible for the studies
* Patients must be American Society of Anesthesiologists (ASA) Class 1 or 2 (generally healthy patients). We plan on studying 100 patients, divided into 5 equally numbered groups. A power analysis of the sample size shows the need for minimum of 20 patients. High risk 3 subgroups (ASA 3), approximately 20 adult patients (included within the 100 planned patients), will be investigated for the (1) RQ correlation with arterial blood gas, (2) for the exercise study and (3) for the esophageal Doppler studies. These study groups include patients that are categorized as ASA 1, 2 or 3, (total of 60 patients) however; the total number of ASA 3 patients will not exceed 20. Subjects having surgeries around the head and neck, as well as surgeries that require the patient to lie face down will be excluded from the study
* Gender and minority status will not be an exclusion factor for any potential study patient

Exclusion Criteria

Cardiovascular:

* Significant vascular disease, especially cardiac and cerebral vascular disease
* Patients will be excluded if they have a history of having a myocardial infarction or cerebral vascular attack
* Significant hypertension (\> 170 systolic, \> 90 diastolic) (except for the high risk subgroup mentioned before)

Pulmonary:

* Significant asthma (mild persistent or greater according to the National Asthma Education and Prevention Program classification system) chronic obstructive pulmonary disease (COPD) (Stage II: Moderate COPD according to the Global Initiative for Chronic Obstructive Lung Disease classification
* Worsening airflow limitation, (FEV1 ≤30% ), and usually the progression of symptoms, with shortness of breath typically developing on exertion), bullous lung disease, or raised intra-cranial pressure (except for the high risk subgroup mentioned before)

Esophageal Doppler:

* If localized pathology is present, including pharyngeal tumor or significant esophageal varices, then the esophageal probe will not be used.

Emergency cases:

* Excluded from the study. Only elective patients will be enrolled.

Short surgeries:

* Surgeries that are expected to last 45 minutes or less will be excluded.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Irvine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter H Breen, MD, FRCPC

Role: PRINCIPAL_INVESTIGATOR

UCI Medical Center

Abraham Rosenbaum, MD

Role: STUDY_DIRECTOR

UCI Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California Irvine Medical Center

Orange, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Rosenbaum A, Kirby C, Breen PH. Measurement of oxygen uptake and carbon dioxide elimination using the bymixer: validation in a metabolic lung simulator. Anesthesiology. 2004 Jun;100(6):1427-37. doi: 10.1097/00000542-200406000-00015.

Reference Type BACKGROUND
PMID: 15166562 (View on PubMed)

Rosenbaum A, Breen PH. Novel, adjustable, clinical bymixer measures mixed expired gas concentrations in anesthesia circle circuit. Anesth Analg. 2003 Nov;97(5):1414-1420. doi: 10.1213/01.ANE.0000083420.15268.3A.

Reference Type BACKGROUND
PMID: 14570659 (View on PubMed)

Breen PH, Isserles SA, Taitelman UZ. Non-steady state monitoring by respiratory gas exchange. J Clin Monit Comput. 2000;16(5-6):351-60. doi: 10.1023/a:1011447500984.

Reference Type BACKGROUND
PMID: 12580218 (View on PubMed)

Breen PH. Importance of temperature and humidity in the measurement of pulmonary oxygen uptake per breath during anesthesia. Ann Biomed Eng. 2000 Sep;28(9):1159-64. doi: 10.1114/1.1312184.

Reference Type BACKGROUND
PMID: 11132200 (View on PubMed)

Breen PH, Serina ER. Bymixer provides on-line calibration of measurement of CO2 volume exhaled per breath. Ann Biomed Eng. 1997 Jan-Feb;25(1):164-71. doi: 10.1007/BF02738547.

Reference Type BACKGROUND
PMID: 9124730 (View on PubMed)

Breen PH, Serina ER, Barker SJ. Measurement of pulmonary CO2 elimination must exclude inspired CO2 measured at the capnometer sampling site. J Clin Monit. 1996 May;12(3):231-6. doi: 10.1007/BF00857644.

Reference Type BACKGROUND
PMID: 8823647 (View on PubMed)

Breen PH, Mazumdar B, Skinner SC. Capnometer transport delay: measurement and clinical implications. Anesth Analg. 1994 Mar;78(3):584-6. doi: 10.1213/00000539-199403000-00027.

Reference Type BACKGROUND
PMID: 8109779 (View on PubMed)

Breen PH, Isserles SA, Harrison BA, Roizen MF. Simple computer measurement of pulmonary VCO2 per breath. J Appl Physiol (1985). 1992 May;72(5):2029-35. doi: 10.1152/jappl.1992.72.5.2029.

Reference Type BACKGROUND
PMID: 1601815 (View on PubMed)

Isserles SA, Breen PH. Can changes in end-tidal PCO2 measure changes in cardiac output? Anesth Analg. 1991 Dec;73(6):808-14. doi: 10.1213/00000539-199112000-00023.

Reference Type BACKGROUND
PMID: 1952183 (View on PubMed)

Rosenbaum A, Breen PH. Importance and interpretation of fast-response airway hygrometry during ventilation of anesthetized patients. J Clin Monit Comput. 2007 Jun;21(3):137-46. doi: 10.1007/s10877-006-9065-5. Epub 2007 Mar 16.

Reference Type RESULT
PMID: 17364215 (View on PubMed)

Rosenbaum A, Kirby C, Breen PH. New metabolic lung simulator: development, description, and validation. J Clin Monit Comput. 2007 Apr;21(2):71-82. doi: 10.1007/s10877-006-9058-4. Epub 2007 Mar 1.

Reference Type RESULT
PMID: 17333487 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

(UCI IRB ID)2005-4256

Identifier Type: OTHER

Identifier Source: secondary_id

R01HL042637

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01 HL 42637 [HS# 2005-4256]

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Minimal Flow Anesthesia and Infection Risk
NCT07092046 ACTIVE_NOT_RECRUITING NA